Humacyte Highlights Robust Expanded Access Program and
In addition to the Company’s eight ongoing clinical trials, HAVs have been used in 13 expanded access cases for emergent life- and limb-saving vascular...
Source: globenewswire.com
Stay updated with breaking news from Michael Curi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In addition to the Company’s eight ongoing clinical trials, HAVs have been used in 13 expanded access cases for emergent life- and limb-saving vascular...